FIA
NTGN

FNY Investment Advisers’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History

FNY Investment Advisers’s Portfolio NTGN Stock Details NTGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-250,000
Closed -$295K – 976
2019
Q4 		$295K Buy
250,000
+40,000
+19% +$63.9K 0.09% 167
2019
Q3 		$361K Buy
+210,000
New +$639K 0.11% 108

Other funds holding NTGN

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Athanor Capital New York $24.6M AUM 2.49% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.2B AUM 44.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FNY Investment Advisers's NTGN Position: Q1 2020 in Review

FNY Investment Advisers sold out of Neon Therapeutics, Inc. Common Stock (NTGN) in Q1 2020, closing a stake of 250,000 shares — an estimated $295K sold.

FNY Investment Advisers first reported a position in NTGN in Q3 2019 and held it in 2 quarters. The position peaked at $361K in Q3 2019. 43 funds tracked by Wall St. Rank hold NTGN as of Q1 2020.

  • FNY Investment Advisers reported no remaining Neon Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • FNY Investment Advisers sold 250,000 Neon Therapeutics, Inc. Common Stock shares in Q1 2020, an estimated $295K.
  • FNY Investment Advisers first reported a position in Neon Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • FNY Investment Advisers's Neon Therapeutics, Inc. Common Stock position peaked at $361K in Q3 2019.
  • 43 funds tracked by Wall St. Rank held Neon Therapeutics, Inc. Common Stock as of Q1 2020.

Based on FNY Investment Advisers's 13F filing for Q1 2020, filed 9 Apr 2020.